BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30658858)

  • 1. Effect of Hydrostatic Pressure, Boundary Constraints and Viscosity on the Vaporization Threshold of Low-Boiling-Point Phase-Change Contrast Agents.
    Rojas JD; Borden MA; Dayton PA
    Ultrasound Med Biol; 2019 Apr; 45(4):968-979. PubMed ID: 30658858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
    Rojas JD; Dayton PA
    Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
    Rojas JD; Dayton PA
    IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents.
    Nyankima AG; Rojas JD; Cianciolo R; Johnson KA; Dayton PA
    Ultrasound Med Biol; 2018 Feb; 44(2):368-376. PubMed ID: 29254872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study.
    Rojas JD; Dayton PA
    Ultrasound Med Biol; 2019 Jan; 45(1):177-191. PubMed ID: 30318123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
    Puett C; Sheeran PS; Rojas JD; Dayton PA
    Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
    Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
    Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound sequence.
    Jing B; Kashyap EP; Lindsey BD
    Med Phys; 2020 Sep; 47(9):4450-4464. PubMed ID: 32657429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
    Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA
    Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hydrostatic pressure on phase-change contrast agent activation by pulsed ultrasound.
    Raut S; Khairalseed M; Honari A; Sirsi SR; Hoyt K
    J Acoust Soc Am; 2019 Jun; 145(6):3457. PubMed ID: 31255129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
    Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
    Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
    Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
    Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Than Bubbles: Creating Phase-Shift Droplets from Commercially Available Ultrasound Contrast Agents.
    Sheeran PS; Yoo K; Williams R; Yin M; Foster FS; Burns PN
    Ultrasound Med Biol; 2017 Feb; 43(2):531-540. PubMed ID: 27727022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Stimulated Phase-Change Contrast Agents for Transepithelial Delivery of Macromolecules, Toward Gastrointestinal Drug Delivery.
    Fix SM; Koppolu BP; Novell A; Hopkins J; Kierski TM; Zaharoff DA; Dayton PA; Papadopoulou V
    Ultrasound Med Biol; 2019 Jul; 45(7):1762-1776. PubMed ID: 31003709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A magnetic droplet vaporization approach using perfluorohexane-encapsulated magnetic mesoporous particles for ultrasound imaging and tumor ablation.
    Teng Z; Wang R; Zhou Y; Kolios M; Wang Y; Zhang N; Wang Z; Zheng Y; Lu G
    Biomaterials; 2017 Jul; 134():43-50. PubMed ID: 28453957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-Guided Ultrasound Characterization of Volatile Sub-Micron Phase-Shift Droplets in the 20-40 MHz Frequency Range.
    Sheeran PS; Daghighi Y; Yoo K; Williams R; Cherin E; Foster FS; Burns PN
    Ultrasound Med Biol; 2016 Mar; 42(3):795-807. PubMed ID: 26725168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents.
    Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L
    Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Encapsulation on in vitro and in vivo Performance of Volatile Nanoscale Phase-Shift Perfluorocarbon Droplets.
    Yoo K; Walker WR; Williams R; Tremblay-Darveau C; Burns PN; Sheeran PS
    Ultrasound Med Biol; 2018 Aug; 44(8):1836-1852. PubMed ID: 29908752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic droplet vaporization is initiated by superharmonic focusing.
    Shpak O; Verweij M; Vos HJ; de Jong N; Lohse D; Versluis M
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1697-702. PubMed ID: 24449879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for acoustic vaporization of encapsulated droplets.
    Guédra M; Coulouvrat F
    J Acoust Soc Am; 2015 Dec; 138(6):3656-67. PubMed ID: 26723321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.